The Novartis Foundation for Sustainable Development, a nonprofit organization whose activities form part of the Corporate Responsibility portfolio of Novartis AG (NVS), announced the launch of a new leprosy strategy based on the consensus reached by a group of leading experts. The new strategy focuses on interrupting leprosy transmission through early diagnosis and treatment, contact tracing of former patients, diagnostic tools and strict surveillance and response.
Moving forward, the Novartis Foundation plans to take steps to demonstrate the feasibility and efficacy of the strategy in several sites in Asia, Africa and Latin America.
For comments and feedback contact: editorial@rttnews.com
Business News